Issues with India's Essential Medicines List
Author Information
Author(s): Manikandan S
Primary Institution: Indira Gandhi Medical College and Research Institute
Hypothesis
A critical analysis of the National Essential Medicines List (NEML) of India 2003 in relation to WHO guidelines.
Conclusion
The NEML 2003 contains numerous errors and omissions that could significantly impact healthcare access in India.
Supporting Evidence
- The NEML 2003 lacks an edition number, which is a standard convention.
- Errors in drug dosages could lead to lack of efficacy or toxic effects.
- Important drugs for treating common conditions are omitted from the NEML.
Takeaway
This study looks at a list of important medicines in India and finds many mistakes that could make it harder for people to get the right medicine when they need it.
Methodology
A critical analysis of the NEML 2003 was conducted to review its compliance with WHO guidelines.
Potential Biases
Potential bias in the selection and interpretation of errors in the NEML.
Limitations
The commentary does not provide empirical data or a systematic review of the NEML.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website